Alison Vogel

Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis

Glomerulonephritis: immunopathogenesis and immunotherapy

Post‐streptococcal glomerulonephritis: Some reduction in a disease of disparities

Corticosteroid-induced osteoporosis in children: outcome after two-year follow-up, risk factors, densitometric predictive cut-off values for vertebral fractures.